Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 217 to 222 of 222 entries
Sorted by: Best Match Show Resources per page
A Retro-orbital Sinus Injection Mouse Model to Study Early Events and Reorganization of the Astrocytic Network during Pneumococcal Meningitis.

Bio-protocol

Bello C, Cohen-Salmon M, Van Nhieu GT.
PMID: 35005087
Bio Protoc. 2021 Dec 05;11(23):e4242. doi: 10.21769/BioProtoc.4242. eCollection 2021 Dec 05.

Pneumococcal (PN) meningitis is a life-threatening disease with high mortality rates that leads to permanent neurological sequelae. Studies of the process of bacterial crossing of the blood brain barrier (BBB) are hampered by the lack of relevant

Cite
Bello C, Cohen-Salmon M, Van Nhieu GT. A Retro-orbital Sinus Injection Mouse Model to Study Early Events and Reorganization of the Astrocytic Network during Pneumococcal Meningitis. Bio Protoc. 2021;11(23):e4242doi: 10.21769/BioProtoc.4242.
Bello, C., Cohen-Salmon, M., & Van Nhieu, G. T. (2021). A Retro-orbital Sinus Injection Mouse Model to Study Early Events and Reorganization of the Astrocytic Network during Pneumococcal Meningitis. Bio-protocol, 11(23), e4242. https://doi.org/10.21769/BioProtoc.4242
Bello, Chakir, et al. "A Retro-orbital Sinus Injection Mouse Model to Study Early Events and Reorganization of the Astrocytic Network during Pneumococcal Meningitis." Bio-protocol vol. 11,23 (2021): e4242. doi: https://doi.org/10.21769/BioProtoc.4242
Bello C, Cohen-Salmon M, Van Nhieu GT. A Retro-orbital Sinus Injection Mouse Model to Study Early Events and Reorganization of the Astrocytic Network during Pneumococcal Meningitis. Bio Protoc. 2021 Dec 05;11(23):e4242. doi: 10.21769/BioProtoc.4242. eCollection 2021 Dec 05. PMID: 35005087; PMCID: PMC8678551.
Copy Download .nbib Format: NLM
Inhibition of metabotropic glutamate receptor III facilitates sensitization to alkylating chemotherapeutics in glioblastoma.

Cell death & disease

Maier JP, Ravi VM, Kueckelhaus J, Behringer SP, Garrelfs N, Will P, Sun N, von Ehr J, Goeldner JM, Pfeifer D, Follo M, Hannibal L, Walch AK, Hofmann UG, Beck J, Heiland DH, Schnell O, Joseph K.
PMID: 34290229
Cell Death Dis. 2021 Jul 21;12(8):723. doi: 10.1038/s41419-021-03937-9.

Glioblastoma (GBM), the most malignant tumor of the central nervous system, is marked by its dynamic response to microenvironmental niches. In particular, this cellular plasticity contributes to the development of an immediate resistance during tumor treatment. Novel insights into...

Cite
Maier JP, Ravi VM, Kueckelhaus J, et al. Inhibition of metabotropic glutamate receptor III facilitates sensitization to alkylating chemotherapeutics in glioblastoma. Cell Death Dis. 2021;12(8):723doi: 10.1038/s41419-021-03937-9.
Maier, J. P., Ravi, V. M., Kueckelhaus, J., Behringer, S. P., Garrelfs, N., Will, P., Sun, N., von Ehr, J., Goeldner, J. M., Pfeifer, D., Follo, M., Hannibal, L., Walch, A. K., Hofmann, U. G., Beck, J., Heiland, D. H., Schnell, O., & Joseph, K. (2021). Inhibition of metabotropic glutamate receptor III facilitates sensitization to alkylating chemotherapeutics in glioblastoma. Cell death & disease, 12(8), 723. https://doi.org/10.1038/s41419-021-03937-9
Maier, Julian P, et al. "Inhibition of metabotropic glutamate receptor III facilitates sensitization to alkylating chemotherapeutics in glioblastoma." Cell death & disease vol. 12,8 (2021): 723. doi: https://doi.org/10.1038/s41419-021-03937-9
Maier JP, Ravi VM, Kueckelhaus J, Behringer SP, Garrelfs N, Will P, Sun N, von Ehr J, Goeldner JM, Pfeifer D, Follo M, Hannibal L, Walch AK, Hofmann UG, Beck J, Heiland DH, Schnell O, Joseph K. Inhibition of metabotropic glutamate receptor III facilitates sensitization to alkylating chemotherapeutics in glioblastoma. Cell Death Dis. 2021 Jul 21;12(8):723. doi: 10.1038/s41419-021-03937-9. PMID: 34290229; PMCID: PMC8295384.
Copy Download .nbib Format: NLM
Surface-Modified Multifunctional Thymol-Loaded Biodegradable Nanoparticles for Topical Acne Treatment.

Pharmaceutics

Folle C, Díaz-Garrido N, Sánchez-López E, Marqués AM, Badia J, Baldomà L, Espina M, Calpena AC, García ML.
PMID: 34575577
Pharmaceutics. 2021 Sep 18;13(9). doi: 10.3390/pharmaceutics13091501.

The present work is focused on the development of novel surface-functionalized poly(lactic-co-glycolic acid) nanoparticles loaded with thymol (TH-NPs) for topical administration enhancing thymol anti-inflammatory, antioxidant and wound healing activities against acne. TH-NPs were prepared by solvent evaporation method using...

Cite
Folle C, Díaz-Garrido N, Sánchez-López E, et al. Surface-Modified Multifunctional Thymol-Loaded Biodegradable Nanoparticles for Topical Acne Treatment. Pharmaceutics. 2021;13(9)doi: 10.3390/pharmaceutics13091501.
Folle, C., Díaz-Garrido, N., Sánchez-López, E., Marqués, A. M., Badia, J., Baldomà, L., Espina, M., Calpena, A. C., & García, M. L. (2021). Surface-Modified Multifunctional Thymol-Loaded Biodegradable Nanoparticles for Topical Acne Treatment. Pharmaceutics, 13(9), . https://doi.org/10.3390/pharmaceutics13091501
Folle, Camila, et al. "Surface-Modified Multifunctional Thymol-Loaded Biodegradable Nanoparticles for Topical Acne Treatment." Pharmaceutics vol. 13,9 (2021). doi: https://doi.org/10.3390/pharmaceutics13091501
Folle C, Díaz-Garrido N, Sánchez-López E, Marqués AM, Badia J, Baldomà L, Espina M, Calpena AC, García ML. Surface-Modified Multifunctional Thymol-Loaded Biodegradable Nanoparticles for Topical Acne Treatment. Pharmaceutics. 2021 Sep 18;13(9). doi: 10.3390/pharmaceutics13091501. PMID: 34575577; PMCID: PMC8471012.
Copy Download .nbib Format: NLM
Dengue fever in a multiple sclerosis patient taking Ocrelizumab.

Multiple sclerosis (Houndmills, Basingstoke, England)

Guerra T, Bollo L, Trojano M, Iaffaldano P.
PMID: 34449289
Mult Scler. 2021 Nov;27(13):2116-2118. doi: 10.1177/13524585211030214. Epub 2021 Aug 27.

Dengue fever (DF) is an endemic infectious disease in tropical and subtropical regions. Ocrelizumab is a humanized monoclonal antibody that targets the CD20 antigen on B cells, which is approved for the treatment of both relapsing-remitting multiple sclerosis (RRMS)...

Cite
Guerra T, Bollo L, Trojano M, et al. Dengue fever in a multiple sclerosis patient taking Ocrelizumab. Mult Scler. 2021;27(13):2116-2118doi: 10.1177/13524585211030214.
Guerra, T., Bollo, L., Trojano, M., & Iaffaldano, P. (2021). Dengue fever in a multiple sclerosis patient taking Ocrelizumab. Multiple sclerosis (Houndmills, Basingstoke, England), 27(13), 2116-2118. https://doi.org/10.1177/13524585211030214
Guerra, Tommaso, et al. "Dengue fever in a multiple sclerosis patient taking Ocrelizumab." Multiple sclerosis (Houndmills, Basingstoke, England) vol. 27,13 (2021): 2116-2118. doi: https://doi.org/10.1177/13524585211030214
Guerra T, Bollo L, Trojano M, Iaffaldano P. Dengue fever in a multiple sclerosis patient taking Ocrelizumab. Mult Scler. 2021 Nov;27(13):2116-2118. doi: 10.1177/13524585211030214. Epub 2021 Aug 27. PMID: 34449289.
Copy Download .nbib Format: NLM
Functionalization of Gold Nanostars with Cationic β-Cyclodextrin-Based Polymer for Drug Co-Loading and SERS Monitoring.

Pharmaceutics

Donoso-González O, Lodeiro L, Aliaga ÁE, Laguna-Bercero MA, Bollo S, Kogan MJ, Yutronic N, Sierpe R.
PMID: 33671975
Pharmaceutics. 2021 Feb 15;13(2). doi: 10.3390/pharmaceutics13020261.

Gold nanostars (AuNSs) exhibit modulated plasmon resonance and have a high SERS enhancement factor. However, their low colloidal stability limits their biomedical application as a nanomaterial. Cationic β-cyclodextrin-based polymer (CCD/P) has low cytotoxicity, can load and transport drugs more...

Cite
Donoso-González O, Lodeiro L, Aliaga ÁE, et al. Functionalization of Gold Nanostars with Cationic β-Cyclodextrin-Based Polymer for Drug Co-Loading and SERS Monitoring. Pharmaceutics. 2021;13(2)doi: 10.3390/pharmaceutics13020261.
Donoso-González, O., Lodeiro, L., Aliaga, �. �. E., Laguna-Bercero, M. A., Bollo, S., Kogan, M. J., Yutronic, N., & Sierpe, R. (2021). Functionalization of Gold Nanostars with Cationic β-Cyclodextrin-Based Polymer for Drug Co-Loading and SERS Monitoring. Pharmaceutics, 13(2), . https://doi.org/10.3390/pharmaceutics13020261
Donoso-González, Orlando, et al. "Functionalization of Gold Nanostars with Cationic β-Cyclodextrin-Based Polymer for Drug Co-Loading and SERS Monitoring." Pharmaceutics vol. 13,2 (2021). doi: https://doi.org/10.3390/pharmaceutics13020261
Donoso-González O, Lodeiro L, Aliaga ÁE, Laguna-Bercero MA, Bollo S, Kogan MJ, Yutronic N, Sierpe R. Functionalization of Gold Nanostars with Cationic β-Cyclodextrin-Based Polymer for Drug Co-Loading and SERS Monitoring. Pharmaceutics. 2021 Feb 15;13(2). doi: 10.3390/pharmaceutics13020261. PMID: 33671975; PMCID: PMC7919026.
Copy Download .nbib Format: NLM
Comparison of Two Immunoassay Screening Methods and a LC-MS/MS in Detecting Traditional and Designer Benzodiazepines in Urine.

Molecules (Basel, Switzerland)

Rossi B, Freni F, Vignali C, Stramesi C, Collo G, Carelli C, Moretti M, Galatone D, Morini L.
PMID: 35011344
Molecules. 2021 Dec 24;27(1). doi: 10.3390/molecules27010112.

Sensitive and specific immunoassay screening methods for the detection of benzodiazepines in urine represent an important prerequisite for routine analysis in clinical and forensic toxicology. Moreover, emerging designer benzodiazepines force labs to keep their methodologies updated, in order to...

Cite
Rossi B, Freni F, Vignali C, et al. Comparison of Two Immunoassay Screening Methods and a LC-MS/MS in Detecting Traditional and Designer Benzodiazepines in Urine. Molecules. 2021;27(1)doi: 10.3390/molecules27010112.
Rossi, B., Freni, F., Vignali, C., Stramesi, C., Collo, G., Carelli, C., Moretti, M., Galatone, D., & Morini, L. (2021). Comparison of Two Immunoassay Screening Methods and a LC-MS/MS in Detecting Traditional and Designer Benzodiazepines in Urine. Molecules (Basel, Switzerland), 27(1), . https://doi.org/10.3390/molecules27010112
Rossi, Brian, et al. "Comparison of Two Immunoassay Screening Methods and a LC-MS/MS in Detecting Traditional and Designer Benzodiazepines in Urine." Molecules (Basel, Switzerland) vol. 27,1 (2021). doi: https://doi.org/10.3390/molecules27010112
Rossi B, Freni F, Vignali C, Stramesi C, Collo G, Carelli C, Moretti M, Galatone D, Morini L. Comparison of Two Immunoassay Screening Methods and a LC-MS/MS in Detecting Traditional and Designer Benzodiazepines in Urine. Molecules. 2021 Dec 24;27(1). doi: 10.3390/molecules27010112. PMID: 35011344; PMCID: PMC8746686.
Copy Download .nbib Format: NLM
Showing 217 to 222 of 222 entries